|
Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant Clinical research trials and Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant. Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant clinical trial. Participants oftentimes recieve the finest healthcare available for their Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant  Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant
Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant
For Condition: Diabetes Mellitus,Kidney Failure
Status: Recruiting
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: Kidney transplantation is the preferred treatment for most end-stage kidney disease. This procedure is limited, however, by two major factors: 1) a shortage of donor organs and 2) organ rejection by the recipient. The National Institute of Diabetes and Digestive and Kidney Diseases is screening patients with kidney failure or diabetes who may be eligible for kidney, kidney and pancreas, or islet cell transplantation. Patients in this screening study are not offered treatment. When the screening is complete, patients will be offered an opportunity to participate in another institute study, or, if there are no active studies appropriate for the patient, other options will be suggested to the primary or referring physician. Patients found eligible for a study are not obligated to participate. Screening for all patients typically consists of blood tests, urinalysis, electrocardiogram, PPD tuberculosis screen and pregnancy test. Chest and kidney X-rays and other studies may be done on patients determined eligible for a particular study, including transplantation. A summary of all test results will be sent to the referring physician unless the patient requests otherwise.
Details: This protocol is designed for screening of patients with renal failure and/or diabetes who may be eligible for kidney, kidney-pancreas, or islet cell transplantation. Its purpose is to allow detailed investigation into the renal and endocrine function of these patients, and the status of other organ systems that would determine their ability to safely tolerate specific aspects of other therapeutic research protocols. After completion of this screening process, the patient will either be offered a chance to participate in an active treatment protocol, or if no appropriate protocol is identified, will have recommendations for other treatment options relayed to the primary or referring physicians.
Eligibility:
Study Type: Observational, Screening
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Patients will be entered on this protocol at the time of their first visit to the NIH Clinical Center Outpatient Clinic or Inpatient Services if: The patient carries the diagnosis of a disorder for which the Transplant and Autoimmunity Branch has active research interest, and based on information received from an outside physician, they meet preliminary eligibility criteria for other specific research protocols. The patient or the patient's guardian is capable of providing informed consent, and signs the informed consent after initial counseling by clinical staff. Separate consent forms for all interventional procedures will be obtained after explanation of the specific procedure. EXCLUSION CRITERIA: History of known malignancies except basal cell carcinoma of the skin. Inability to give legal informed consent by self or legal guardian. Inbility or willingness to comply with protocol monitoring and therapy, including, among others, a history of noncompliance, circumstances where compliance with protocol requirements is not feasible due to living conditions, travel restrictions, access to urgent medical services, or access to anti-rejection drugs after the research protocol is completed.
Total Enrollment: 999
Location and Contact Information:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 990120; 99-DK-0120
Study Start Date: June 4, 1999
Record last reviewed: May 28, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001859
Other Diabetes Mellitus Studies:
1. Assessing Continuous Glucose Monitors in Healthy Children
2. Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy Study)
3. Aging and Cellular Mechanism for Insulin Action after Exercise Training
4. Laser and Medical Treatment of Diabetic Macular Edema
5. Safety and Efficacy of Xenical in Children and Adolescents with Obesity-Related Diseases
Related Studies:
Other Diabetes Mellitus Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant
|
|
|
|
|
|
|
|
